The independent source for health policy research, polling, and news.
701 - 720 of 805 Results
Some argue that vaccines capable of preventing any COVID-19 symptoms should qualify for widespread use, but others want much larger trials to prove the vaccines can reduce hospitalizations or deaths.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Heres a collection of their appearances.
To stop the coronavirus, we need to stop super-spreader events.
President Donald Trump is one of at least two dozen people tied to the White House who have tested positive for COVID-19. Negotiations on the next round of COVID relief are off again maybe. And the FDA and CDC continue to fight for scientific credibility. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Erin Mershon of Stat News join KHNs Julie Rovner to discuss these issues and more. Plus, Rovner interviews Amy Howe of SCOTUSblog about what the Supreme Court might do with the latest case challenging the constitutionality of the Affordable Care Act.
During this, the first and only vice presidential debate of the 2020 election season, the two candidates clashed over the coronavirus and other health care issues, as well as a range of other topics.
California and at least five other states have said they may independently vet any vaccines. Experts warn that could needlessly confuse the public.
Approval of a vaccine will be an important step in defeating COVID-19. But it wont immediately end the pandemic.
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
President Donald Trump has the legal power to authorize a COVID vaccine over the objections of the Food and Drug Administration and vaccine manufacturers. Such a move could further erode public trust in a vaccine and foist an unsafe shot on Americans.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Heres a collection of their appearances.
The National Institutes of Health has suggested minorities should be overrepresented in COVID-19 vaccine trials perhaps at rates that aredouble their percentage of the U.S. population. But efforts to recruit patients from racial minority groups are just beginning, while some trials have already advanced to phase 3.
The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurological condition is linked to the vaccine. But regulators are frustrated by a lack of information from the drugmaker.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal governments preeminent health agencies the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHNs Julie Rovner to discuss this and more. Plus, Rovner interviews KHNs Elizabeth Lawrence about the latest KHN-NPR Bill of the Month installment.
About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.
Traditionally, requirements that kids undergo certain immunizations before attending school have been a critical public health tool. Health officials are scrambling to make sure children dont fall through the cracks.
Efforts are underway to bring to market a vaccine for valley fever, a fungal infection with COVID-like symptoms that occurs in the deserts of the Southwest. The illness is getting more attention as cases rise and a warming climate threatens to spread it through the West.
As the nation awaits a vaccine to end the pandemic, local health departments say they lack the staff, money, tools and a unified plan to distribute, administer and track millions of vaccines, most of which will require two doses. Dozens of doctors, nurses and health officials interviewed by KHN and The Associated Press expressed their concern and frustration over federal shortcomings.
The nations top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.
Donald Trump accepted his party's nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.
穢 2026 KFF